These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34002696)

  • 1. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.
    Aguilar JI; Cheng MH; Font J; Schwartz AC; Ledwitch K; Duran A; Mabry SJ; Belovich AN; Zhu Y; Carter AM; Shi L; Kurian MA; Fenollar-Ferrer C; Meiler J; Ryan RM; Mchaourab HS; Bahar I; Matthies HJ; Galli A
    Elife; 2021 May; 10():. PubMed ID: 34002696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacochaperoning in a
    Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
    Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
    Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS.
    Reith MEA; Jones KT; Zhen J; Topiol S
    Bioorg Med Chem Lett; 2018 Feb; 28(3):470-475. PubMed ID: 29258773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.
    Hamilton PJ; Campbell NG; Sharma S; Erreger K; Herborg Hansen F; Saunders C; Belovich AN; ; Sahai MA; Cook EH; Gether U; McHaourab HS; Matthies HJ; Sutcliffe JS; Galli A
    Mol Psychiatry; 2013 Dec; 18(12):1315-23. PubMed ID: 23979605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Caenorhabditis elegans model to study dopamine transporter deficiency syndrome.
    Illiano P; Lanzo A; Leo D; Paglione M; Zampi G; Gainetdinov RR; Di Schiavi E
    Eur J Neurosci; 2017 Jan; 45(1):207-214. PubMed ID: 27519790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
    Beerepoot P; Lam VM; Salahpour A
    J Biol Chem; 2016 Oct; 291(42):22053-22062. PubMed ID: 27555326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.
    Bowton E; Saunders C; Reddy IA; Campbell NG; Hamilton PJ; Henry LK; Coon H; Sakrikar D; Veenstra-VanderWeele JM; Blakely RD; Sutcliffe J; Matthies HJ; Erreger K; Galli A
    Transl Psychiatry; 2014 Oct; 4(10):e464. PubMed ID: 25313507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family.
    Heidari E; Razmara E; Hosseinpour S; Tavasoli AR; Garshasbi M
    Ann Hum Genet; 2020 Jul; 84(4):315-323. PubMed ID: 32077500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors.
    DiCarlo GE; Aguilar JI; Matthies HJ; Harrison FE; Bundschuh KE; West A; Hashemi P; Herborg F; Rickhag M; Chen H; Gether U; Wallace MT; Galli A
    J Clin Invest; 2019 May; 129(8):3407-3419. PubMed ID: 31094705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
    J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
    Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
    Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.
    Fraser R; Chen Y; Guptaroy B; Luderman KD; Stokes SL; Beg A; DeFelice LJ; Gnegy ME
    Mol Pharmacol; 2014 Jul; 86(1):76-85. PubMed ID: 24753048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
    Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
    Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.
    Ng J; Zhen J; Meyer E; Erreger K; Li Y; Kakar N; Ahmad J; Thiele H; Kubisch C; Rider NL; Morton DH; Strauss KA; Puffenberger EG; D'Agnano D; Anikster Y; Carducci C; Hyland K; Rotstein M; Leuzzi V; Borck G; Reith ME; Kurian MA
    Brain; 2014 Apr; 137(Pt 4):1107-19. PubMed ID: 24613933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
    Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism.
    Ng J; Barral S; De La Fuente Barrigon C; Lignani G; Erdem FA; Wallings R; Privolizzi R; Rossignoli G; Alrashidi H; Heasman S; Meyer E; Ngoh A; Pope S; Karda R; Perocheau D; Baruteau J; Suff N; Antinao Diaz J; Schorge S; Vowles J; Marshall LR; Cowley SA; Sucic S; Freissmuth M; Counsell JR; Wade-Martins R; Heales SJR; Rahim AA; Bencze M; Waddington SN; Kurian MA
    Sci Transl Med; 2021 May; 13(594):. PubMed ID: 34011628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Rescue of a Misfolded
    Kasture A; El-Kasaby A; Szöllősi D; Asjad HMM; Grimm A; Stockner T; Hummel T; Freissmuth M; Sucic S
    J Biol Chem; 2016 Sep; 291(40):20876-20890. PubMed ID: 27481941
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.